Novozymes A/S (LON:0Q4U)

Novozymes Statistics

Total Valuation

Novozymes has a market cap or net worth of GBP 20.90 billion. The enterprise value is 23.36 billion.

Market Cap	20.90B
Enterprise Value	23.36B

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	Aug 25, 2025

Share Statistics

Current Share Class	411.90M
Shares Outstanding	n/a
Shares Change (YoY)	-30.69%
Shares Change (QoQ)	-0.92%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	24.07%
Float	346.37M

Valuation Ratios

The trailing PE ratio is 43.77 and the forward PE ratio is 24.88.

PE Ratio	43.77
Forward PE	24.88
PS Ratio	5.78
PB Ratio	2.23
P/TBV Ratio	n/a
P/FCF Ratio	30.60
P/OCF Ratio	21.33
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.65, with an EV/FCF ratio of 34.21.

EV / Earnings	48.93
EV / Sales	6.48
EV / EBITDA	15.65
EV / EBIT	23.79
EV / FCF	34.21

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.29.

Current Ratio	1.61
Quick Ratio	0.98
Debt / Equity	0.29
Debt / EBITDA	1.81
Debt / FCF	3.97
Interest Coverage	16.62

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.49%
Return on Capital Employed (ROCE)	7.50%
Weighted Average Cost of Capital (WACC)	7.75%
Revenue Per Employee	341,688
Profits Per Employee	45,120
Employee Count	10,582
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Novozymes has paid 132.24 million in taxes.

Income Tax	132.24M
Effective Tax Rate	21.69%

Stock Price Statistics

The stock price has decreased by -4.56% in the last 52 weeks. The beta is 0.78, so Novozymes's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-4.56%
50-Day Moving Average	399.94
200-Day Moving Average	419.06
Relative Strength Index (RSI)	41.12
Average Volume (20 Days)	67,181

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novozymes had revenue of GBP 3.62 billion and earned 477.46 million in profits. Earnings per share was 1.67.

Revenue	3.62B
Gross Profit	2.12B
Operating Income	987.64M
Pretax Income	609.69M
Net Income	477.46M
EBITDA	1.50B
EBIT	987.64M
Earnings Per Share (EPS)	1.67

Balance Sheet

The company has 245.54 million in cash and 2.71 billion in debt, with a net cash position of -2.47 billion.

Cash & Cash Equivalents	245.54M
Total Debt	2.71B
Net Cash	-2.47B
Net Cash Per Share	n/a
Equity (Book Value)	9.38B
Book Value Per Share	20.06
Working Capital	649.58M

Cash Flow

In the last 12 months, operating cash flow was 979.79 million and capital expenditures -296.86 million, giving a free cash flow of 682.93 million.

Operating Cash Flow	979.79M
Capital Expenditures	-296.86M
Free Cash Flow	682.93M
FCF Per Share	n/a

Margins

Gross margin is 58.55%, with operating and profit margins of 27.32% and 13.20%.

Gross Margin	58.55%
Operating Margin	27.32%
Pretax Margin	16.86%
Profit Margin	13.20%
EBITDA Margin	41.48%
EBIT Margin	27.32%
FCF Margin	18.89%

Dividends & Yields

This stock pays an annual dividend of 0.74, which amounts to a dividend yield of 0.19%.

Dividend Per Share	0.74
Dividend Yield	0.19%
Dividend Growth (YoY)	62.46%
Years of Dividend Growth	1
Payout Ratio	73.62%
Buyback Yield	30.69%
Shareholder Yield	30.88%
Earnings Yield	2.28%
FCF Yield	3.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 28, 2011. It was a forward split with a ratio of 5.

Last Split Date	Nov 28, 2011
Split Type	Forward
Split Ratio	5

Scores

Novozymes has an Altman Z-Score of 4.34 and a Piotroski F-Score of 4.

Altman Z-Score	4.34
Piotroski F-Score	4